Zhittya Genesis Medicine, Inc.
Dr. Jack Jacobs is president of Zhittya Genesis, a biopharmaceutical company developing a biological drug which triggers angiogenesis and neurogenesis. He leads the company's efforts to obtain FDA approval for its drug to treat Parkinson's Disease, ALS, Alzheimer's, multiple sclerosis, and enhance stroke recovery.
Content from Jack Jacobs
New regenerative biopharmaceutical products are now under clinical development to stimulate the body...